Neurocrine Bioscience buy Truist Financial Co.
Start price
17.02.26
/
50%
€107.85
Target price
17.02.27
€118.20
Performance (%)
5.80%
Price
02.04.26
€114.10
Summary
This prediction is currently active. With a performance of 5.80%, the BUY prediction by Truist_Financial_Co_ for Neurocrine Bioscience is trending in the right direction. This prediction currently runs until 17.02.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 2.378% | 2.378% |
| iShares Core DAX® | 4.852% | -4.418% |
| iShares Nasdaq 100 | 3.999% | -3.283% |
| iShares Nikkei 225® | 4.221% | -6.223% |
| iShares S&P 500 | 3.324% | -3.174% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target lowered by analysts at Truist Financial Corporation from $169.00 to $140.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€116.75
08.01.26
08.01.26
€144.77
08.01.27
08.01.27
-2.27%
02.04.26
02.04.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€119.35
30.10.25
30.10.25
€148.09
30.10.26
30.10.26
-4.40%
02.04.26
02.04.26